Navigation Links
Doubts Cast On Benefits Of Vitamin E,,

Studies on vitamin E seemed to suggest that supplementing the diet with vitamin E helps in preventing cancer and heart problems. //Recently, a study published In Journal Of American Medical association, says the reality of taking vitamin E supplements may be something very different.

The researchers had studied patients with cardiovascular diseases through Heart Outcomes Prevention Evaluation or HOPE centers between 1993 and 1999, and the extended program of HOPE- The Ongoing Outcomes or HOPE-TOO from 1999 to 2003. All the participants in the trial were given a daily dose of natural source of vitamin E or matching placebo.

The study results show that in patients with cardiovascular disease or diabetes mellitus, higher doses of vitamin E supplements taken for a long time do not show any positive effect in preventing cancer or any major cardiac problems. On the other hand, taking such a supplement of vitamin E may increase the risk of ischemia or of heart failure in people.

The recommended dietary allowance for vitamin E is 15mg daily. However, the supplements available in the market contain 400 to 800mg, while the multivitamins contain much less doses. Hence any supplement of vitamin E taken daily for long term may cause more damage than good.

Reference: http://jama.ama-assn.org/cgi/content/short/293/11/1338
'"/>




Page: 1

Related medicine news :

1. U.N. Official Doubts India On AIDS Data
2. Dummy Usage Raises Doubts.
3. Doubts Over Chinas HIV/AIDS Estimates
4. Doubts About In UteroTransmission Of Senile Amyloidosis
5. Freshness Dating? Researchers Express Doubts
6. Benefits in fertility procedures
7. Benefits of Vitamin Supplements Unclear
8. Benefits of Eating Whole Grains, Fruits and Vegetables
9. Benefits of Nitric Oxide in the Treatment of Premature Infants
10. Benefits and Risks of Asthma Treatment Questioned
11. Benefits Of The Worlds Most Widely Used Beverage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... PHILADELPHIA (PRWEB) , ... July 24, 2017 , ... ... Health , two organizations that already work hand-in-hand on an Innovation Collaboration program, ... transform the access, quality, experience and cost of the care members and patients ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 (the ... adipose filtration technology. The '398 and '324 patents cover methods and systems ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
(Date:7/24/2017)... ... July 24, 2017 , ... A ... focused on delivering end-to-end sleep health care at scale, indicates record-breaking adherence ... that adherence rates for positive airway pressure (PAP) therapy, the most widely utilized ...
(Date:7/24/2017)... Calif. (PRWEB) , ... July 24, 2017 , ... A ... from food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: ... instances in her life and how she has risen above. , In “Memories,” readers ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology: